Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 3
2017 4
2018 5
2019 2
2020 3
2021 1
2022 5
2023 4
2024 6
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Engineering immune-evasive allogeneic cellular immunotherapies.
Martin KE, Hammer Q, Perica K, Sadelain M, Malmberg KJ. Martin KE, et al. Among authors: hammer q. Nat Rev Immunol. 2024 Sep;24(9):680-693. doi: 10.1038/s41577-024-01022-8. Epub 2024 Apr 24. Nat Rev Immunol. 2024. PMID: 38658708 Review.
Guidelines for the use of flow cytometry and cell sorting in immunological studies.
Cossarizza A, Chang HD, Radbruch A, Akdis M, Andrä I, Annunziato F, Bacher P, Barnaba V, Battistini L, Bauer WM, Baumgart S, Becher B, Beisker W, Berek C, Blanco A, Borsellino G, Boulais PE, Brinkman RR, Büscher M, Busch DH, Bushnell TP, Cao X, Cavani A, Chattopadhyay PK, Cheng Q, Chow S, Clerici M, Cooke A, Cosma A, Cosmi L, Cumano A, Dang VD, Davies D, De Biasi S, Del Zotto G, Della Bella S, Dellabona P, Deniz G, Dessing M, Diefenbach A, Di Santo J, Dieli F, Dolf A, Donnenberg VS, Dörner T, Ehrhardt GRA, Endl E, Engel P, Engelhardt B, Esser C, Everts B, Dreher A, Falk CS, Fehniger TA, Filby A, Fillatreau S, Follo M, Förster I, Foster J, Foulds GA, Frenette PS, Galbraith D, Garbi N, García-Godoy MD, Geginat J, Ghoreschi K, Gibellini L, Goettlinger C, Goodyear CS, Gori A, Grogan J, Gross M, Grützkau A, Grummitt D, Hahn J, Hammer Q, Hauser AE, Haviland DL, Hedley D, Herrera G, Herrmann M, Hiepe F, Holland T, Hombrink P, Houston JP, Hoyer BF, Huang B, Hunter CA, Iannone A, Jäck HM, Jávega B, Jonjic S, Juelke K, Jung S, Kaiser T, Kalina T, Keller B, Khan S, Kienhöfer D, Kroneis T, Kunkel D, Kurts C, Kvistborg P, Lannigan J, Lantz O, Larbi A, LeibundGut-Landmann S, Leipold MD, … See abstract for full author list ➔ Cossarizza A, et al. Among authors: hammer q. Eur J Immunol. 2017 Oct;47(10):1584-1797. doi: 10.1002/eji.201646632. Eur J Immunol. 2017. PMID: 29023707 Free PMC article. No abstract available.
TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells.
Sekine T, Perez-Potti A, Nguyen S, Gorin JB, Wu VH, Gostick E, Llewellyn-Lacey S, Hammer Q, Falck-Jones S, Vangeti S, Yu M, Smed-Sörensen A, Gaballa A, Uhlin M, Sandberg JK, Brander C, Nowak P, Goepfert PA, Price DA, Betts MR, Buggert M. Sekine T, et al. Among authors: hammer q. Sci Immunol. 2020 Jul 3;5(49):eaba7918. doi: 10.1126/sciimmunol.aba7918. Sci Immunol. 2020. PMID: 32620560
Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia.
Haroun-Izquierdo A, Vincenti M, Netskar H, van Ooijen H, Zhang B, Bendzick L, Kanaya M, Momayyezi P, Li S, Wiiger MT, Hoel HJ, Krokeide SZ, Kremer V, Tjonnfjord G, Berggren S, Wikström K, Blomberg P, Alici E, Felices M, Önfelt B, Höglund P, Valamehr B, Ljunggren HG, Björklund A, Hammer Q, Kveberg L, Cichocki F, Miller JS, Malmberg KJ, Sohlberg E. Haroun-Izquierdo A, et al. Among authors: hammer q. J Immunother Cancer. 2022 Nov;10(11):e005577. doi: 10.1136/jitc-2022-005577. J Immunother Cancer. 2022. PMID: 36319065 Free PMC article.
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies.
Hammer Q, Perica K, Mbofung RM, van Ooijen H, Martin KE, Momayyezi P, Varady E, Pan Y, Jelcic M, Groff B, Abujarour R, Krokeide SZ, Lee T, Williams A, Goodridge JP, Valamehr B, Önfelt B, Sadelain M, Malmberg KJ. Hammer Q, et al. Cell Stem Cell. 2024 Sep 5;31(9):1376-1386.e8. doi: 10.1016/j.stem.2024.06.011. Epub 2024 Jul 8. Cell Stem Cell. 2024. PMID: 38981470 Free article.
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.
Hammer Q, Rückert T, Borst EM, Dunst J, Haubner A, Durek P, Heinrich F, Gasparoni G, Babic M, Tomic A, Pietra G, Nienen M, Blau IW, Hofmann J, Na IK, Prinz I, Koenecke C, Hemmati P, Babel N, Arnold R, Walter J, Thurley K, Mashreghi MF, Messerle M, Romagnani C. Hammer Q, et al. Nat Immunol. 2018 May;19(5):453-463. doi: 10.1038/s41590-018-0082-6. Epub 2018 Apr 9. Nat Immunol. 2018. PMID: 29632329
Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptor.
Sætersmoen M, Kotchetkov IS, Torralba-Raga L, Mansilla-Soto J, Sohlberg E, Krokeide SZ, Hammer Q, Sadelain M, Malmberg KJ. Sætersmoen M, et al. Among authors: hammer q. Med. 2025 Feb 14;6(2):100521. doi: 10.1016/j.medj.2024.09.010. Epub 2024 Oct 17. Med. 2025. PMID: 39423821 Free article.
Tissue origin and virus specificity shape human CD8+ T cell cytotoxicity.
Niessl J, Müller TR, Constantz C, Cai C, Nilsén V, Rivera Ballesteros O, Adamo S, Kammann T, Mouchtaridi E, Gao Y, Akhirunnesa M, Raineri EJM, Weigel W, Kokkinou E, Stamper C, Marchalot A, Bassett J, Ferreira S, Rodahl I, Wild N, Stellaccio T, Brownlie D, Ringqvist E, Flodström-Tullberg M, Llewellyn-Lacey S, Tibbitt C, Hammer Q, Michaëlsson J, Price DA, Mjösberg J, Marquardt N, Sandberg JK, Sekine T, Jorns C, Buggert M. Niessl J, et al. Among authors: hammer q. Sci Immunol. 2025 Jul 18;10(109):eadq4881. doi: 10.1126/sciimmunol.adq4881. Epub 2025 Jul 18. Sci Immunol. 2025. PMID: 40680144
NK cells in COVID-19-from disease to vaccination.
Hammer Q, Cuapio A, Bister J, Björkström NK, Ljunggren HG. Hammer Q, et al. J Leukoc Biol. 2023 Oct 26;114(5):507-512. doi: 10.1093/jleuko/qiad031. J Leukoc Biol. 2023. PMID: 36976012 Review.
High-Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma.
Wirth L, Weigel W, Stamper CT, Kolmert J, de Souza Ferreira S, Hammer Q, Sparreman Mikus M, Theorell J, Andersson L 1st, Lantz AS, Wallén-Nielsen E, Petrén A, Wheelock CE, Bossios A, Lazarinis N, Malinovschi A, Janson C, Dahlén B, Hochdörfer T, Tibbitt CA, Dahlén SE, Yasinska V, Mjösberg J. Wirth L, et al. Among authors: hammer q. Allergy. 2025 Sep;80(9):2541-2556. doi: 10.1111/all.16633. Epub 2025 Jun 26. Allergy. 2025. PMID: 40566935 Free PMC article.
34 results